Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells?

✍ Scribed by Mlejnek, P

• Book ID: 110056223
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 140 KB
• Volume: 19
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2403701